ClinicalTrials.gov record
Completed Phase 2 Interventional

Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

ClinicalTrials.gov ID: NCT00002632

Public ClinicalTrials.gov record NCT00002632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 11:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PHASE II TRIAL OF TAXOL IN ADVANCED OR METASTATIC SALIVARY GLAND MALIGNANCIES

Study identification

NCT ID
NCT00002632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
32 participants

Conditions and interventions

Interventions

  • paclitaxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 29, 1995
Primary completion
Apr 30, 2002
Completion
Not listed
Last update posted
Jun 14, 2023

Started 1995

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Veterans Affairs Medical Center - Palo Alto Palo Alto California 94304
Stanford University Medical Center Stanford California 94305-5408
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612
Emory University Hospital - Atlanta Atlanta Georgia 30322
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611
Veterans Affairs Medical Center - Chicago (Lakeside) Chicago Illinois 60611
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Johns Hopkins Oncology Center Baltimore Maryland 21287
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Duluth Duluth Minnesota 55805
University of Minnesota Cancer Center Minneapolis Minnesota 55455
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Veterans Affairs Medical Center - East Orange East Orange New Jersey 07018-1095
CCOP - Northern New Jersey Hackensack New Jersey 07601
University of Rochester Cancer Center Rochester New York 14642
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461
Ireland Cancer Center Cleveland Ohio 44106-5065
Hahnemann University Hospital Philadelphia Pennsylvania 19102-1192
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213
Veterans Affairs Medical Center - Nashville Nashville Tennessee 37212
Vanderbilt Cancer Center Nashville Tennessee 37232-6838
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →